Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

Visually impaired UFS student an inspiration
2016-10-05

Description: Zingisa Ngwenya Tags: Zingisa Ngwenya

Zingisa Ngwenya at the 2016
Spring Graduation Ceremony at the Callie Human
Centre on the UFS Bloemfontein Campus.
Photo: Johan Roux

“Zingisa, I saw the tears streaming down your face when you were being hooded,” said an emotional Dr Khotso Mokhele, Chancellor of the University of the Free State. “And you were not the only one with tears streaming down your face.”
 
Zingisa Ngwenya, a visually impaired BA Communication Science student, was one of those who graduated at the UFS 2016 Spring Graduation on 15 September 2016 at the Bloemfontein Campus. By her side were her guardians, Derek Watts, the presenter of the current affairs TV programme Carte Blanche, and his wife Belinda.

Dream becomes reality with support from community
Watts first met Ngwenya at the Audi Pioneer School Rally in Worcester, Western Cape, in which she was his co-driver. He admired her ability to read all her instructions in braille. “I was inspired by her because she had lost her sight late in her school career,” said Watts at the graduation ceremony. Ngwenya was academically strong and her aspirations to go to university led to the relationship.  

The UFS Centre for Universal Access and Disability Support, the Kirsty Watts Foundation, Gavin Fourie from Richmond, and Symington and De Kok law firm in Bloemfontein helped make Ngwenya’s dream a reality. “We managed the facility for her to do well, but it’s nothing compared to what she has done to get this degree,” Watts said.

Support from Watts family made things possible
Ngwenya will be studying towards a law degree at UFS, as well as working part-time at, Symington and De Kok. “She never bemoans what has happened to her in life. She just looks ahead to make the most of her life,” Watts said.

“Derek and Belinda’s support means everything to me. Without them it would not have been possible because it has really been a struggle, but they believed in me,” Ngwenya said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept